Recruiting
Phase 1

rQNestin34.5v.2

Sponsor:

Dana-Farber Cancer Institute

Code:

NCT03152318

Conditions

Malignant Glioma of Brain

Astrocytoma

Malignant Astrocytoma

Oligodendroglioma

Anaplastic Oligodendroglioma of Brain (Diagnosis)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

rQNestin

Cyclophosphamide

Stereotactic biopsy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2025-07-08.